Encompass Health Corp (EHC) to Post Q1 2019 Earnings of $0.90 Per Share, Jefferies Financial Group Forecasts

Encompass Health Corp (AMEX:EHC) – Research analysts at Jefferies Financial Group decreased their Q1 2019 EPS estimates for Encompass Health in a research report issued on Sunday, February 10th. Jefferies Financial Group analyst B. Tanquilut now expects that the company will earn $0.90 per share for the quarter, down from their previous estimate of $0.96. Jefferies Financial Group has a “Buy” rating on the stock. Jefferies Financial Group also issued estimates for Encompass Health’s Q2 2019 earnings at $0.98 EPS, Q3 2019 earnings at $0.95 EPS, Q4 2019 earnings at $0.96 EPS, FY2019 earnings at $3.78 EPS and FY2020 earnings at $3.89 EPS.

Other research analysts have also recently issued reports about the company. Zacks Investment Research upgraded Encompass Health from a “hold” rating to a “buy” rating and set a $76.00 price objective for the company in a research note on Wednesday, October 31st. UBS Group initiated coverage on Encompass Health in a report on Thursday, November 15th. They set a “buy” rating and a $86.00 target price on the stock. Finally, Barclays initiated coverage on Encompass Health in a report on Friday, December 14th. They set an “equal weight” rating and a $75.00 target price on the stock. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $72.82.

Encompass Health has a 12 month low of $40.86 and a 12 month high of $59.29.

Encompass Health (AMEX:EHC) last announced its quarterly earnings data on Thursday, February 7th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.01. The firm had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.09 billion. During the same quarter in the previous year, the business earned $0.70 earnings per share. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year.

A number of institutional investors have recently bought and sold shares of EHC. Vanguard Group Inc. grew its holdings in Encompass Health by 2.2% in the third quarter. Vanguard Group Inc. now owns 9,285,576 shares of the company’s stock valued at $723,811,000 after purchasing an additional 200,890 shares during the period. Morgan Stanley grew its holdings in Encompass Health by 25.8% in the third quarter. Morgan Stanley now owns 638,008 shares of the company’s stock valued at $49,731,000 after purchasing an additional 130,728 shares during the period. Rehmann Capital Advisory Group grew its holdings in Encompass Health by 8,546.8% in the third quarter. Rehmann Capital Advisory Group now owns 193,082 shares of the company’s stock valued at $2,477,000 after purchasing an additional 190,849 shares during the period. Nordea Investment Management AB grew its holdings in Encompass Health by 13.6% in the third quarter. Nordea Investment Management AB now owns 57,325 shares of the company’s stock valued at $4,468,000 after purchasing an additional 6,856 shares during the period. Finally, TIAA CREF Investment Management LLC grew its holdings in Encompass Health by 5.0% in the third quarter. TIAA CREF Investment Management LLC now owns 1,362,083 shares of the company’s stock valued at $106,174,000 after purchasing an additional 64,497 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

See Also: What is a back-end load?

Earnings History and Estimates for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply